日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics

HMA联合维奈托克与强化化疗治疗极高危细胞遗传学AML的疗效比较

Aguirre, Luis E; Bewersdorf, Jan Philipp; Liu, Yiwen; Shallis, Rory M; Boussi, Leora; Zucenka, Andrius; Garciaz, Sylvain; Bystrom, Rebecca P; DeAngelo, Daniel J; Stone, Richard M; Luskin, Marlise R; Garcia, Jacqueline S; Winer, Eric S; Ling, Kelly; Chen, Evan C; Wadleigh, Martha; Berton, Guillaume; Stein, Eytan M; Goldberg, Aaron D; Mendez, Lourdes; Zeidan, Amer M; Sallman, David A; Shimony, Shai; Stahl, Maximilian

Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1

达沙替尼通过降解MCL1来克服对BCL2抑制剂耐药的AML细胞。

Garciaz, Sylvain; Montersino, Camille; Bourgoin, Maxence; Jacquel, Arnaud; Castellano, Rémy; Guille, Arnaud; Chaffanet, Max; Bertucci, François; Hospital, Marie-Anne; Adélaïde, José; Auberger, Patrick; Vey, Norbert; Collette, Yves

Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly Diagnosed Acute Myeloid Leukemia

老年新诊断急性髓系白血病患者入住重症监护室的预后

Berton, Guillaume; Hospital, Marie-Anne; Garciaz, Sylvain; Rouzaud, Camille; Maisano, Valerio; Hicheri, Yosr; D'Incan Corda, Evelyne; Rey, Jerome; Bisbal, Magali; Sannini, Antoine; Chine, Laurent Chow; Servan, Luca; Gonzalez, Frederic; Vey, Norbert; Mokart, Djamel; Saillard, Colombe

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

HLA-A2-WT1 CD3双特异性抗体RO7283420治疗复发/难治性急性髓系白血病的剂量递增研究

Hutchings, Martin; Korfi, Koorosh; Montesinos, Pau; Santoro, Armando; Hou, Hsin-An; Martinez-Sanchez, Pilar; Vives, Susana; Galimberti, Sara; Chen, Tsai-Yun; Frigeni, Marco; Garciaz, Sylvain; Salamero Garcia, Olga; Yeh, Su-Peng; Yee, Karen; Esteve, Jordi; Bajel, Ashish; Fleming, Shaun; Bretz, Anne Catherine; Attig, Jan; Sun, Min; Nassiri, Sina; Rutishauser, Tobias; Klein, Christian; Ma, Y May; Schnetzler, Gabriel; Vauleon, Stephanie; Yu, Huixin; Barata, Teresa; Richard, Muriel; Simon, Silke; Hinton, Heather; Keshelava, Nino; Subklewe, Marion

Caspase-2 protects against ferroptotic cell death

Caspase-2 可防止铁凋亡细胞死亡

Swati Dawar, Mariana C Benitez, Yoon Lim, Toby A Dite, Jumana M Yousef, Niko Thio, Sylvain Garciaz, Thomas D Jackson, Julia V Milne, Laura F Dagley, Wayne A Phillips, Sharad Kumar, Nicholas J Clemons1

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML

NPM1突变型急性髓系白血病中,强化诱导化疗与去甲基化药物联合维奈托克的疗效比较

Bewersdorf, Jan Philipp; Shimony, Shai; Shallis, Rory M; Liu, Yiwen; Berton, Guillaume; Schaefer, Eva J; Zeidan, Amer M; Goldberg, Aaron D; Stein, Eytan M; Marcucci, Guido; Bystrom, Rebecca P; Lindsley, R Coleman; Chen, Evan C; Ramos Perez, Jorge; Stein, Anthony; Pullarkat, Vinod; Aldoss, Ibrahim; DeAngelo, Daniel J; Neuberg, Donna S; Stone, Richard M; Garciaz, Sylvain; Ball, Brian; Stahl, Maximilian

Venetoclax Resistance in Acute Myeloid Leukemia

急性髓系白血病中的维奈托克耐药性

Garciaz, Sylvain; Hospital, Marie-Anne; Collette, Yves; Vey, Norbert

Downregulation of stromal syntenin sustains AML development

基质蛋白的下调维持 AML 的发展

Raphael Leblanc, Rania Ghossoub, Armelle Goubard, Rémy Castellano, Joanna Fares, Luc Camoin, Stephane Audebert, Marielle Balzano, Berna Bou-Tayeh, Cyril Fauriat, Norbert Vey, Sylvain Garciaz, Jean-Paul Borg, Yves Collette, Michel Aurrand-Lions, Guido David, Pascale Zimmermann

Targeting regulated cell death pathways in acute myeloid leukemia

靶向急性髓系白血病中的调控性细胞死亡通路

Garciaz, Sylvain; Miller, Thomas; Collette, Yves; Vey, Norbert

FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile

FMS样酪氨酸激酶3抑制剂在急性髓系白血病治疗中的应用:最新证据和安全性概况

Garciaz, Sylvain; Hospital, Marie-Anne